Oblimersen and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia

Clinical trial NCT00049192 · COMPLETED

Trial details

NCT number: NCT00049192
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Myelogenous Leukemia, BCR-ABL1 Positive Chronic Phase Chronic Myelogenous Leukemia Relapsing Chronic Myelogenous Leukemia

Start date: 2002-11-01
Primary completion: 2005-11-01
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.